...
AGIOMEGA

Agios Pharmaceuticals, Inc.

HealthcareBiotechnology
$30.23
$0.00(+0.83%)
52W$22.24
$46.00
FinancialsValuationvs VRTX
Updated Mar 1, 12:00 AM
RSI62
RS Rating33/99
Beta0.91
Volatility71%
F-Score3/9
Mkt Cap$2.25T
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Agios Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Earnings contraction of 111% provides fundamental context to the price action. Investors should exercise caution due to high volatility (71% annualized), which requires wider risk management.

Relative Strength
33
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.91
vs S&P 500
MARKET
52W Position
34%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$27.79
50 SMA > 100 SMA$32.11
100 SMA > 150 SMA$33.91
150 SMA > 200 SMA$34.10

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$28.31+6.77%ABOVE
50 SMA$27.79+8.79%ABOVE
100 SMA$32.11-5.87%BELOW
150 SMA$33.91-10.85%BELOW
200 SMA$34.10-11.34%BELOW

Price Performance

1D+0.8%
1W+0.1%
1M+6.8%
3M+3.5%
6M-20.8%
YTD+11.2%
1Y-14.9%
3Y+6.1%
52-Week Trading Range34% from low
$30.23
52W Low$22.24
52W High$46.00

Technical Indicators

RSI (14)BULLISH
62.3
305070
VCP ScoreCOOL
6/10
Base depth: 22.6%

Risk Profile

Beta
0.91
52W Vol
71%
ATR
$1.17
Max DD (1Y)
-51%

Volume Analysis

Today
30
50D Avg
947.7K
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q4'24+2%
$-1.69
Q1'25-7%
$-1.55
Q2'25-14%
$-1.93
Q3'25-111%
$-1.78
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-0.90%
5 Years:—
3 Years:+55.97%
TTM:+36.26%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:-161.18%

Stock Price CAGR

10 Years:-2.35%
5 Years:-8.65%
3 Years:+6.10%
1 Year:-14.94%

Return on Equity

10Y Avg:-17.2%
5Y Avg:32.1%
3Y Avg:-3.2%
Last Year:-31.2%

Key Metrics

Market Cap$2.25T
Gross Margin88.3%
Net Margin-7.6%
Piotroski F-Score3/9

More AGIO Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

AGIO vs VRTXVRTXASNDBBIOBMRN

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 33 meansAGIO outperformed 33% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.91 means 9% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 3/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with COOL status.

Frequently Asked Questions

Is AGIO in an uptrend right now?

AGIO has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is AGIO overbought or oversold?

AGIO's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.

Is AGIO outperforming the market?

AGIO has a Relative Strength (RS) Rating of 33 out of 99. AGIO is currently lagging the broader market.

Where is AGIO in its 52-week range?

AGIO is trading at $30.23, which is 66% of its 52-week high ($46.00) and 34% above its 52-week low ($22.24).

How volatile is AGIO?

AGIO has a Beta of 0.91 and 52-week volatility of 71%. It's less volatile than the S&P 500 - generally more stable.